FI885279L - Menetelmä 2 3-sidoksen tunnistavan monoklonaalisen vasta-aineen valmistamiseksi ja vasta-ainetta tuottava hybridooma - Google Patents
Menetelmä 2 3-sidoksen tunnistavan monoklonaalisen vasta-aineen valmistamiseksi ja vasta-ainetta tuottava hybridooma Download PDFInfo
- Publication number
- FI885279L FI885279L FI885279A FI885279A FI885279L FI 885279 L FI885279 L FI 885279L FI 885279 A FI885279 A FI 885279A FI 885279 A FI885279 A FI 885279A FI 885279 L FI885279 L FI 885279L
- Authority
- FI
- Finland
- Prior art keywords
- bond
- preparing
- antibody
- hybridoma producing
- monoclonal antibody
- Prior art date
Links
- 210000004408 hybridoma Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
- Y10S424/807—Monoclonal
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
- Y10S530/864—Monoclonal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62290310A JP2754206B2 (ja) | 1987-11-17 | 1987-11-17 | α２→３結合を認識するモノクローナル抗体 |
| JP29031087 | 1987-11-17 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI885279A0 FI885279A0 (fi) | 1988-11-15 |
| FI885279L true FI885279L (fi) | 1989-05-18 |
| FI95043B FI95043B (fi) | 1995-08-31 |
| FI95043C FI95043C (fi) | 1995-12-11 |
Family
ID=17754449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI885279A FI95043C (fi) | 1987-11-17 | 1988-11-15 | Menetelmä 2 3-sidoksen tunnistavan monoklonaalisen vasta-aineen valmistamiseksi ja vasta-ainetta tuottava hybridooma |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5141864A (fi) |
| EP (1) | EP0316882B1 (fi) |
| JP (1) | JP2754206B2 (fi) |
| KR (1) | KR960014441B1 (fi) |
| CN (1) | CN1042734A (fi) |
| AT (1) | ATE108482T1 (fi) |
| AU (1) | AU624583B2 (fi) |
| CA (1) | CA1337800C (fi) |
| DE (1) | DE3850634T2 (fi) |
| FI (1) | FI95043C (fi) |
| HU (1) | HU204573B (fi) |
| IL (1) | IL88400A (fi) |
| NO (1) | NO173556C (fi) |
| NZ (1) | NZ226974A (fi) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4107154A1 (de) * | 1990-10-11 | 1992-04-16 | Boehringer Mannheim Gmbh | Monoklonale antikoerper gegen melanom |
| DE4208795A1 (de) * | 1992-03-19 | 1993-09-23 | Behringwerke Ag | Monoklonaler anti-gangliosid-antikoerper, seine herstellung und verwendung als tumortherapeutikum |
| CN1057128C (zh) * | 1993-09-22 | 2000-10-04 | 南通医学院 | 感觉神经抗体及其制备方法 |
| US5674681A (en) * | 1994-12-06 | 1997-10-07 | Rothenberg; Barry E. | Methods to identify hemochromatosis |
| CU23007A1 (es) * | 2001-04-06 | 2004-12-17 | Ct De Inmunologia Molecular Ct De Inmunologia Mole | Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos |
| CN100347296C (zh) * | 2003-03-28 | 2007-11-07 | 财团法人富山县新世纪产业机构 | 使用单个抗原特异性b淋巴细胞制备产生抗原特异性抗体的杂交瘤的方法以及单克隆抗体的制备方法 |
| FI20070199A0 (fi) * | 2007-03-08 | 2007-03-08 | Glykos Finland Oy | Uusia happamia N-glykaanirakenteita |
| EP2606897A1 (en) | 2011-12-22 | 2013-06-26 | Laboratorios Del. Dr. Esteve, S.A. | Methods and compositions for the treatment of diseases caused by enveloped viruses |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4507391A (en) * | 1982-04-02 | 1985-03-26 | Sloan-Kettering Institute For Cancer Research | Method for detecting the presence of GD3 ganglioside |
-
1987
- 1987-11-17 JP JP62290310A patent/JP2754206B2/ja not_active Expired - Lifetime
-
1988
- 1988-11-11 KR KR1019880014846A patent/KR960014441B1/ko not_active Expired - Fee Related
- 1988-11-14 US US07/270,205 patent/US5141864A/en not_active Expired - Fee Related
- 1988-11-15 AT AT88119045T patent/ATE108482T1/de not_active IP Right Cessation
- 1988-11-15 EP EP88119045A patent/EP0316882B1/en not_active Expired - Lifetime
- 1988-11-15 NZ NZ226974A patent/NZ226974A/en unknown
- 1988-11-15 FI FI885279A patent/FI95043C/fi not_active IP Right Cessation
- 1988-11-15 DE DE3850634T patent/DE3850634T2/de not_active Expired - Fee Related
- 1988-11-16 CA CA000583272A patent/CA1337800C/en not_active Expired - Fee Related
- 1988-11-16 CN CN88107887A patent/CN1042734A/zh active Pending
- 1988-11-16 HU HU885935A patent/HU204573B/hu not_active IP Right Cessation
- 1988-11-16 NO NO885113A patent/NO173556C/no unknown
- 1988-11-17 AU AU25186/88A patent/AU624583B2/en not_active Ceased
- 1988-11-17 IL IL88400A patent/IL88400A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01132374A (ja) | 1989-05-24 |
| HU204573B (en) | 1992-01-28 |
| KR960014441B1 (ko) | 1996-10-15 |
| IL88400A (en) | 1993-06-10 |
| NO173556B (no) | 1993-09-20 |
| CN1042734A (zh) | 1990-06-06 |
| DE3850634T2 (de) | 1994-10-27 |
| NO173556C (no) | 1993-12-29 |
| HUT48679A (en) | 1989-06-28 |
| FI95043C (fi) | 1995-12-11 |
| CA1337800C (en) | 1995-12-26 |
| FI885279A0 (fi) | 1988-11-15 |
| KR890008320A (ko) | 1989-07-10 |
| NZ226974A (en) | 1990-03-27 |
| US5141864A (en) | 1992-08-25 |
| EP0316882A3 (en) | 1990-03-14 |
| FI95043B (fi) | 1995-08-31 |
| DE3850634D1 (de) | 1994-08-18 |
| NO885113D0 (no) | 1988-11-16 |
| ATE108482T1 (de) | 1994-07-15 |
| IL88400A0 (en) | 1989-06-30 |
| NO885113L (no) | 1989-05-18 |
| AU2518688A (en) | 1989-05-25 |
| AU624583B2 (en) | 1992-06-18 |
| JP2754206B2 (ja) | 1998-05-20 |
| EP0316882B1 (en) | 1994-07-13 |
| EP0316882A2 (en) | 1989-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0186833A3 (en) | A cytotoxic protein, a process for its isolation, a monoclonal antibody ct-1 and a hyrbridoma producing the same | |
| EP0171496A3 (en) | A chimera monoclonal antibody and a production process thereof | |
| FI954347L (fi) | Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat | |
| HU896763D0 (en) | Process for the preparation of bispecific monoclonal antibody | |
| RO100383A2 (ro) | Metoda de obtinere a unui anticorp monoclonal | |
| FI900332A7 (fi) | Ilmentämisjärjestelmä kimeeristen monoklonaalisten vasta-aineiden tuottamiseksi | |
| FI925631A7 (fi) | Monoklonaaliset vasta-aineet | |
| NO302176B1 (no) | Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen | |
| DE3885355D1 (de) | Monoklonale Antikörper. | |
| SG50680A1 (en) | Method for the production of monoclonal antibodies utilizing a germfree animal | |
| PT90323A (pt) | Processo para a preparacao de anticorpos monoclonais | |
| ES554206A0 (es) | Un metodo para producir anticuerpos monoclonales | |
| FI885279L (fi) | Menetelmä 2 3-sidoksen tunnistavan monoklonaalisen vasta-aineen valmistamiseksi ja vasta-ainetta tuottava hybridooma | |
| IT1199239B (it) | Linfochina,anticorpo monoclonale specifico per tale linfochina,e procedimento per la loro produzione | |
| GB2158094B (en) | Anti-human igg monoclonal antibody and process for preparing the same | |
| DK210087A (da) | Heterohybridomacelle, der danner et monoklonalt anti-rhesus d-antistof | |
| ES557082A0 (es) | Un procedimiento para producir un anticuerpo monoclonal | |
| FI881158L (fi) | Menetelmä terapeuttisesti käyttökelpoisen immunoglobuliinikonjugaatin valmistamiseksi | |
| DK717888D0 (da) | Monoklonale antistoffer | |
| DK144485D0 (da) | Monoklonale antistoffer | |
| ES555741A0 (es) | Un metodo para producir anticuerpos monoclonales humanos | |
| GB8727030D0 (en) | Production of monoclonal antibodies | |
| AU4465489A (en) | Monoclonal antibody specifically recognizing n-glycolyl type gm2 hybridoma producing the antibody and method for preparing the hybridoma | |
| FI862131L (fi) | Menetelmä hybridoomasolulinjan ja sen tuottaman vasta-aineen tuottamiseksi | |
| IL97827A0 (en) | Monoclonal anti-igm antibodies,their production and use,and hybridomas for producing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: MECT CORPORATION |